Pacific Biosciences: Chris Smith, David Meline
Chris Smith has been appointed to the board of directors of Pacific Biosciences, replacing David Meline, who resigned from the board. Smith is the CEO of oncology testing services firm NeoGenomics. Previously, he was chairman and CEO of Ortho Clinical Diagnostics, and before that, CEO of Cochlear. He holds a BS in journalism from Texas A&M University.